Where Will Moderna Be in 1 Year?
A lot can happen in 12 months, as investors can testify. A year ago, equity markets were flying high, but things aren't so rosy now. Some companies have been hit particularly hard throughout this ordeal, and biotech giant Moderna (NASDAQ: MRNA) is one of them.
The vaccine maker has lost a little more than half of its value over the trailing 12-month period, partly because many investors think sales of its coronavirus vaccine, Spikevax, will drop off a cliff after this year. The coming 12 months could be crucial for Moderna, but what will they have in store for the company? Let's dig in and find out.
Source Fool.com
